Linyan Xu

760 total citations
44 papers, 516 citations indexed

About

Linyan Xu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Linyan Xu has authored 44 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Linyan Xu's work include Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linyan Xu is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Linyan Xu collaborates with scholars based in China, United States and Australia. Linyan Xu's co-authors include Liu X, Ling Su, Jian‐Ping Lang, Zhi‐Gang Ren, Chunyu Liu, Kailin Xu, Shiyuan Liu, David James Young, Hui-Fang Wang and Wentao An and has published in prestigious journals such as Blood, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Linyan Xu

39 papers receiving 510 citations

Peers

Countries citing papers authored by Linyan Xu

Since Specialization

Citations

This map shows the geographic impact of Linyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linyan Xu more than expected).

Fields of papers citing papers by Linyan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linyan Xu. The network helps show where Linyan Xu may publish in the future.

Co-authorship network of co-authors of Linyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linyan Xu. A scholar is included among the top collaborators of Linyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linyan Xu. Linyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Is bottom-of-the-pyramid orientation a new reason for product imitation in emerging markets? 2025 ·International Business Review ·Linyan Xu, Zelong Wei, (unknown), Eric W.T. Ngai, (unknown)	1
2	Impact of relative estradiol changes during ovarian stimulation on blastocyst formation and live birth in assisted reproductive technology 2025 ·Scientific Reports ·(unknown), Lihui Wei, (unknown), (unknown), (unknown), (unknown), (unknown), Linyan Xu, Jingjing Li, Li Fan	0
3	A Combination of CPI-0610 and SAHA Induces Apoptosis through STAT3 and p38 Signalling Pathways in Diffuse Large B-cell Lymphoma Cells 2023 ·Current Medicinal Chemistry ·Linyan Xu, (unknown), (unknown), Mengdi Liu, Yuanyuan Qin, Meng Zhang, Dongmei Yan, (unknown), (unknown), (unknown), (unknown)	3
4	Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma 2023 ·Journal of Pharmacology and Experimental Therapeutics ·Linyan Xu, Meng Zhang, (unknown), (unknown), Tianyi Lu, (unknown), (unknown), Shuo Zhang, (unknown), Dongmei Yan, Xiangmin Wang, Wei Sang	4
5	Thymosin β4 Exerts a Cytoprotective Function and Attenuates Liver Injury in Murine Hepatic Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Xiangmin Wang, (unknown), (unknown), Qing Zhang, Hongyuan Zhou, (unknown), (unknown), Yuhan Wang, (unknown), Linyan Xu, Meng Zhang, Dongmei Yan, Lingyu Zeng, Kailin Xu, Wei Sang	0
6	Associations among risk perception, health efficacy, and health behaviors for cardiovascular disease: an application of risk perception attitude framework 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), Yun Chen, Yuping Zhang, (unknown), (unknown), Linyan Xu, Jingfen Jin	8
7	Epidemiological and clinical features in patients with coronavirus disease 2019 outside of Wuhan, China: Special focus in asymptomatic patients 2021 ·PLoS neglected tropical diseases ·Ping Liu, Ruichao Niu, Jie Chen, Yuling Tang, Wenfang Tang, Linyan Xu, (unknown)	14
8	CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia 2021 ·Journal of Molecular Medicine ·(unknown), Jiawen Xu, Rong Wang, Ting Pan, Huan-Xin Zhang, Lingling Yin, (unknown), Linyan Xu, Shengyun Zhu, Qing‐Yun Wu, Zhenyu Li, (unknown), Kailin Xu, Mingshan Niu	5
9	Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era 2021 ·International Journal of Hematology ·Wei Sang, (unknown), Yuanyuan Qin, Ziyuan Shen, Dongmei Yan, Cai Sun, (unknown), Yuhan Ma, (unknown), (unknown), (unknown), (unknown), Linyan Xu, (unknown), Kailin Xu	6
10	Prognostic Analysis of Patients with Primary Extranodal Lymphoma: A Retrospective Study 2021 ·Cancer Management and Research ·(unknown), Lingling Jiang, Linlin Nie, (unknown), (unknown), Lingling Yin, Linyan Xu, Jieyun Xia, (unknown), Feng Zhu, Kailin Xu	2
11	EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells 2020 ·Journal of Cancer ·Linyan Xu, Xiang Gao, Yang Pu, Wei Sang, Jun Jiao, Mingshan Niu, Mengdi Liu, Yuanyuan Qin, Dongmei Yan, (unknown), Cai Sun, Yu Tian, Feng Zhu, Ziyuan Shen, Lingyu Zeng, Zhenyu Li, Kailin Xu	8
12	Cladribine Induces ATF4 Mediated Apoptosis and Synergizes with SAHA in Diffuse Large B-Cell Lymphoma Cells 2020 ·International Journal of Medical Sciences ·Linyan Xu, Jun Jiao, Ziyuan Shen, Wei Sang, Xiang Gao, Yang Pu, Dongmei Yan, (unknown), Cai Sun, Mengdi Liu, Yuanyuan Qin, Yu Tian, Feng Zhu, Lingyu Zeng, Zhenyu Li, Kailin Xu	11
13	MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia 2019 ·Frontiers in Oncology ·Mingshan Niu, (unknown), Rong Wang, Tingting Shao, Feng Yuan, (unknown), Xuejiao Liu, Kai Zhao, Shengyun Zhu, Linyan Xu, (unknown), Kailin Xu	3
14	MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy 2018 ·Journal of Translational Medicine ·Chen Yang, Tingting Shao, Huihui Zhang, (unknown), Xiaoying Shi, Xuejiao Liu, (unknown), Linyan Xu, Shengyun Zhu, Jiang Cao, Hai Cheng, Zhiling Yan, Zhenyu Li, Mingshan Niu, Kailin Xu	16
15	MicroRNA-150 negatively regulates the function of CD4+ T cells through AKT3/Bim signaling pathway 2016 ·Cellular Immunology ·Wei Sang, Cai Sun, Cong Zhang, Dianzheng Zhang, Ying Wang, Linyan Xu, Zhe Zhang, Xiangyu Wei, Bin Pan, Dongmei Yan, Feng Zhu, Zhiling Yan, Jiang Cao, Thomas P. Loughran, Kailin Xu	29
16	Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level 2016 ·Oncology Reports ·Chunling Fu, Yanqing Gong, (unknown), Zengtian Sun, Mingshan Niu, Wei Sang, Linyan Xu, (unknown), Ying Wang, Kailin Xu	12
17	Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation 2015 ·Scientific Reports ·Jianlin Qiao, Yujin Huang, Yuan Xia, (unknown), (unknown), Linyan Xu, Kunming Qi, Yun Liu, Kailin Xu, Lingyu Zeng	20
18	Correlations between serum levels of 25-hydroxyvitamin D and carotid atherosclerosis in patients with type 2 diabetes in Shanghai 2014 ·Annales d Endocrinologie ·Ruihua Chen, (unknown), Quan Jiang, (unknown), (unknown), Bin Zhou, (unknown), Linyan Xu, Yufeng Zou	10
19	PKCδ Regulates Death Receptor 5 Expression Induced by PS-341 through ATF4–ATF3/CHOP Axis in Human Lung Cancer Cells 2012 ·Molecular Cancer Therapeutics ·Linyan Xu, Ling Su, Liu X	44
20	Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross–section study 2012 ·Annales d Endocrinologie ·Ruihua Chen, (unknown), Xiaohui Zhao, (unknown), (unknown), (unknown), Bin Zhou, (unknown), Linyan Xu, Yufeng Zou	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact